Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy.
Gilquin
J
J
Viard
J P
JP
Jubault
V
V
Sert
C
C
Kazatchkine
M D
MD
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D005260:Female; D006111:Graves Disease / Q000276:immunology*; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D019469:Indinavir / Q000008:administration & dosage / Q000009:adverse effects; D019259:Lamivudine / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D019438:Ritonavir / Q000008:administration & dosage / Q000009:adverse effects; D018119:Stavudine / Q000008:administration & dosage / Q000009:adverse effects
D019380:Anti-HIV Agents; D019259:Lamivudine; D019469:Indinavir; D018119:Stavudine; D019438:Ritonavir